Exelixis Drug Improves Overall Survival in Liver Cancer Patients Exelixis Drug Improves Overall Survival in Liver Cancer Patients

Exelixis Inc ' s drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company ' s shares soaring 31%.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news